Loading…

Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa

The WHO guidelines for the management of advanced HIV disease recommend a package of care consisting of rapid initiation of antiretroviral therapy (ART), enhanced screening and diagnosis of tuberculosis (TB) and cryptococcal meningitis, co-trimoxazole prophylaxis, isoniazid preventive therapy (IPT),...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2019-03, Vol.19 (1), p.261-261, Article 261
Main Authors: Benzekri, Noelle A, Sambou, Jacques F, Ndong, Sanou, Tamba, Ibrahima Tito, Faye, Dominique, Diallo, Mouhamadou Baïla, Diatta, Jean Phillippe, Faye, Khadim, Sall, Ibrahima, Sall, Fatima, Manga, Noël Magloire, Malomar, Jean Jacques, Ndour, Cheikh T, Hawes, Stephen E, Seydi, Moussa, Gottlieb, Geoffrey S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The WHO guidelines for the management of advanced HIV disease recommend a package of care consisting of rapid initiation of antiretroviral therapy (ART), enhanced screening and diagnosis of tuberculosis (TB) and cryptococcal meningitis, co-trimoxazole prophylaxis, isoniazid preventive therapy (IPT), fluconazole pre-emptive therapy, and adherence support. The goals of this study were to determine the prevalence of advanced HIV disease among individuals initiating ART in Senegal, to identify predictors of advanced disease, and to evaluate adherence to the WHO guidelines. This study was conducted among HIV-positive individuals initiating ART in Dakar and Ziguinchor, Senegal. Clinical evaluations, laboratory analyses, questionnaires and chart review were conducted. Logistic regression was used to identify predictors of advanced disease. A total of 198 subjects were enrolled; 70% were female. The majority of subjects (71%) had advanced HIV disease, defined by the WHO as a CD4 count
ISSN:1471-2334
1471-2334
DOI:10.1186/s12879-019-3826-5